NCT00153842 - A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Carcinoma, Non-small-cell Lung

Interventions

DRUG

Bexarotene (targretin)

"Bexarotene oral capsules will be administered daily beginning on the initial day of chemotherapy (day 1).~Level 1: 300 mg"

DRUG

Bexarotene (targretin)

"Bexarotene oral capsules will be administered daily beginning on the intitial day of chemotherapy (Day 1).~Level 2: 400 mg"

Trial Locations (1)

Norris Cotton Cancer Center, Lebanon